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Abstract
Aberrant aggregation and amyloid formation of tar DNA binding protein (TDP-43) and a-synuclein (aS)
underlie frontotemporal dementia (FTD) and Parkinson’s disease (PD), respectively. Amyloid inclusions
of TDP-43 and aS are also commonly co-observed in amyotrophic lateral sclerosis (ALS), dementia with
Lewy bodies (DLB) and Alzheimer disease (AD). Emerging evidence from cellular and animal models
show colocalization of the TDP-43 and aS aggregates, raising the possibility of direct interactions and
co-aggregation between the two proteins. In this report, we set out to answer this question by investigating
the interactions between aS and prion-like pathogenic C-terminal domain of TDP-43 (TDP-43 PrLD). PrLD
is an aggregation-prone fragment generated both by alternative splicing as well as aberrant proteolytic
cleavage of full length TDP-43. Our results indicate that two proteins interact in a synergistic manner to
augment each other’s aggregation towards hybrid fibrils. While monomers, oligomers and sonicated fibrils
of aS seed TDP-43 PrLD monomers, TDP-43 PrLD fibrils failed to seed aS monomers indicating selectivity in interactions. Furthermore, aS modulates liquid droplets formed by TDP-43 PrLD and RNA to promote insoluble amyloid aggregates. Importantly, the cross-seeded hybrid aggregates show greater
cytotoxicity as compared to the individual homotypic aggregates suggesting that the interactions between
the two proteins have a discernable impact on cellular functions. Together, these results bring forth
insights into TDP-43 PrLD – aS interactions that could help explain clinical and pathological presentations
in patients with co-morbidities involving the two proteins.
Published by Elsevier Ltd.

Introduction
Protein misfolding and toxic amyloid formation
have come to define the pathogenesis of many
neurodegenerative disorders including Alzheimer
disease (AD), Parkinson’s disease (PD),
amyotrophic
lateral
sclerosis
(ALS)
and
0022-2836/Published by Elsevier Ltd.

frontotemporal dementia (FTD).1,2 Each of these
pathologies is known to involve aberrant aggregation of a protein that brings to bear cellular abnormalities and toxicities. However, overlapping
clinical presentations and comorbidities observed
among patients with neurodegenerative diseases
have motivated researchers into investigating the
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possibility of molecular overlaps among the respective amyloidogenic proteins involved. For example,
a wealth of evidence accrued over the years indicate
that some of these maladies are accompanied by
the deposition of common amyloid proteins such
as tau and a-synuclein (aS), collectively referred to
as tauopathies and synucleinopathies, respectively.3–5 Abnormal tau inclusions are often
observed alongside amyloid-b (Ab) deposits in AD
patients6 as well as in conditions such as PD7,8
and prion disease.9,10 Similarly aS, the major protein involved in the formation of pathogenic amyloid
inclusions of Lewy bodies (LBs) in PD is also
observed in AD,11 dementia with Lewy bodies
(DLB), and multiple system atrophy (MSA).12,13 Like
tau and aS, insoluble cytoplasmic inclusions of the
ribonucleoprotein, tar DNA binding protein (TDP43) are increasingly observed in many neurodegenerative pathologies such as ALS and FTD,14 as well
as in patients with PD, DLB, and AD15,16. There has
been a surge in the reports on cross-interactions
between amyloidogenic proteins such as the interactions between Ab/tau, aS/Ab, aS/tau,8,17–19 and
prion/Ab,20 which have cemented the hypothesis
that cross-interaction mechanisms better define
the underlying cause of neurogenerative diseases
and related co-pathogenesis. Along the same lines,
recently it has come to light that aS and TDP-43
inclusions also co-exist in ALS, FTD and PD.15,21
While both aS and TDP-43 are known to independently form cytoplasmic amyloid inclusions,22–25
their co-existence raises the question of whether
they interact with one another and if so, what consequence does such an interaction brings to bear.
Indeed, recent reports do support this contention;
TDP-43 was observed to synergistically interact
and enhance aS toxicity in dopaminergic neurons,26
while immunocytochemical and immunoblot analyses on mice models and SH-SY5Y neuroblastoma
cells revealed that exogenous aS fibrils promote
phosphorylation and aggregation of TDP-43.19 Furthermore, co-expression of TDP-43 and aS was
shown to induce aS pathology in C. elegans that
led to significant neurodegeneration as compared
to their individual expressions .27
aS is a 140 amino acid protein containing three
regions; lipid binding N-terminal domain (NTD), an
aggregation-prone non-amyloid component (NAC)
middle region, and an intrinsically disordered,
charged C-terminal domain (CTD). NAC and a
part of NTD are the primary regions responsible
for aggregation, while CTD seems to play an
inhibitory role for this process.28,29 On the other
hand, TDP-43 is a 414 amino acid containing
ribonucloprotein protein with an N-terminal domain,
two RNA recognition motifs (RRMs), and a disordered prion-like C-terminal domain (PrLD) containing low complexity sequences.30 TDP-43 is known
to be involved in transcriptional regulation and
RNA splicing.31,32 In pathology, the protein is
translocated into the cytoplasm where it undergoes

aberrant proteolytic cleavage that generates different C-terminal fragments (CTFs; C35, C25, and
C18), which consequently form toxic insoluble inclusions.33–38 Furthermore, under stress conditions,
cytoplasmic TDP-43 undergoes liquid–liquid phase
separation (LLPS) by coacervating with RNA and
other proteins to form membraneless stress granules (SGs).39,40 If and how SGs play a role in the formation of cytoplasmic TDP-43 inclusions and
cellular toxicity remains unclear. PrLD, a segment
of such pathological aggregates, is primarily known
to drive the fibrillization process and mediates protein–protein interactions.41,42 Despite multiple factors in regulating fibrillization of TDP-43 PrLD, a
common biophysical phenomenon, liquid–liquid
phase separation (LLPS) is also recently known to
modulate the aggregation process via electrostatic
interactions.40
Here, we sought to determine how aS and TDP43 interact with one another to exacerbate cellular
toxicity, by investigating the full-length aS and
TDP-43 PrLD as PrLD forms a key part of
pathogenic proteolytic products of TDP-43
(Figure 1(a) and (b)). Our results indicate that aS
and TDP-43 PrLD monomers, oligomers or fibrils
cross-interact and modulate each other’s
aggregation behavior. Moreover, aS also enhance
TDP-43 PrLD aggregation by modulating the liquid
droplets formed by the phase separation of TDP43 PrLD in presence of RNA. In all, cross-seeded
aggregates show higher cytotoxicity than the
individual aggregates suggesting the potential for
such mechanisms to present greater pathogenicity.

Results
aS and TDP-43 PrLD monomers synergistically
promote fibrillization
First, we questioned whether monomers of aS
and TDP-43 PrLD are able to interact with one
another. To answer this, heteronuclear multiple
quantum coherence (HMQC) spectroscopy was
performed on a uniformly 15N labeled aS and
TDP-43 PrLD individually. Both proteins showed
narrow chemical shift dispersions in the amide
region (7.8–8.7 ppm for aS and 7.7–8.5 for TDP43 PrLD in the 1H dimension) confirming the wellknown disordered structures for both the proteins
(blue; Figure 1(c) and (d)). To see whether the
two proteins interact with one another, HMQC
spectra of the 15N-enriched proteins were
observed upon incubating with unlabeled, natural
isotope-abundant
proteins
in
equimolar
concentrations at 37 °C. The spectrum of aS coincubated with unlabeled TDP-43 PrLD showed
disappearance of several cross-peaks along with
significant changes in the chemical shifts (Figure 1
(c)). The disappearance of peaks is largely
attributed to the aggregation of proteins which
often leads to significant line broadening and/or
loss of signal intensities.43,44 Interestingly, large
2
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Figure 1. 1H-15N HMQC spectroscopy of aS and TDP-43 PrLD along with DLS of respective reactions. a-b)
Sequence of full-length 1–140 amino acid residues aS (a) and 267–414 amino acid residues TDP-43 PrLD used in the
experiment. c) 1H-15N HMQC of 10 lM 15N-labeled aS monomers alone (blue) or in the presence of unlabeled 10 lM
TDP-43 PrLD monomers (red) in 20 mM MES buffer pH 6.0 at 37 °C. Some of the residues undergoing chemical shift
perturbations (CSPs) are shown in boxes while those with lost peaks are indicated by letters without boxes. d) 1H-15N
HMQC of 10 lM 15N-labeled TDP-43 PrLD monomers alone (blue) or in presence of unlabeled aS (red). e) CSPs for
qﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
equimolar incubations of aS and TDP-43 PrLD that were calculated using the equation, Dd= ðdHÞ2 þ 0:14ðdNÞ2 from
the spectrum in (c). f-g) DLS histograms of 10 lM aS monomer control, TDP-43 PrLD monomer control and coincubated mixture 1:1 aS and TDP-43 PrLD in the same buffer and temperature conditions taken within 10 min of
incubation.

shifts in cross-peaks appear to be more on to the Nand C-terminal domains of aS (residues 1–60 and
100–140; boxes, Figure 1(c)). Considering that the
N- and C-terminal domains are charged and NAC
domain of aS is prone to amyloid formation, it is possible that TDP-43 PrLD induces aggregation of the
NAC domain aS. Similarly, a substantial signal loss
of cross-peaks was observed for TDP-43 PrLD
upon co-incubation with aS indicating potential
aggregation of the former (Figure 1(d)). In order to
confirm the NMR observations, aggregation of the
co-incubated samples was analyzed by dynamic
light scattering (DLS) analysis. The freshly fractionated control monomers of aS and TDP-43 PrLD
showed a hydrodynamic diameter of ~5 nm individually (Figure 1(f) and (g)). One has to bear in mind
that even the SEC fractionated monomers may be
a mixture containing a small percentage of small oligomers. In contrast, the co-incubated samples

showed aggregation with an average diameter of
>103 nm within 10 min of incubation (Figure 1(h)).
These results confirm the NMR observations that
aS and TDP-43 PrLD interact with one another to
promote high molecular weight aggregates.
Encouraged by these NMR results, a deeper investigation into the dynamics of interactions between
the two proteins by means of T2 relaxations and
H/D exchange will be carried out and will be
reported in the near future, but the data obtained
so far unequivocally indicates the interactions
between aS and TDP-43 PrLD.
To further understand the mechanism of aS and
TDP-43 PrLD interactions, we set forth to
investigate the aggregation kinetics using
thioflavin T (ThT) fluorescence assay (Figure 2).
In one reaction set, aS concentration was held
constant at 20 lM while TDP-43 PrLD
concentrations were increased from 1 to 20 lM
3
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Figure 2. ThT aggregation kinetics of monomeric aS and TDP-43 PrLD in 20 mM MES buffer at pH 6.0 a) ThT
fluorescence of 20 lM aS (4) in presence of 0.05 to 1 molar ratio of TDP-43 PrLD to aS (d) and respective TDP-43
PrLD controls (). b) ThT fluorescence of 20 lM TDP-43 PrLD () in presence of 0.05 to 2 molar ratio of aS to TDP-43
PrLD (d) and respective aS controls (4). The data were fit with Boltzmann’s sigmoidal function (see Materials and
Methods) to derive lag time information.

(0.05, 0.25, 0.5 and 1.0 molar equivalents). The
reactions were incubated at 37 °C and the kinetics
of aggregation was monitored for 48 h (Figure 2
(a)). All the data points were plotted and fitted
using the Boltzmann sigmoidal fit (see Methods).
The control aS did not show any aggregation
during this period (4; Figure 2(a)). Similarly, at the
lowest concentration (1 lM), TDP-43 PrLD control
did not show increase in ThT fluorescence
(Figure 2(a)). TDP-43 PrLD control at 5, 10, and
20
lM
showed
concentration-dependent
aggregation with aggregation lag times of 20,
15.4, and 9.6 h, respectively; (; Figure 2(a)),
while the co-incubated samples with aS showed
significantly decreased lag times (d; Figure 2(a))
suggesting
synergistic
augmentation
of
aggregation between the two proteins. In addition,
the co-incubated samples showed higher ThT
intensities, which could either indicate numerically
more fibrils or an increased ThT binding vis-à-vis
higher fluorescence per fibrils formed by both aS
and TDP-43 PrLD. Next, to investigate whether aS
can modulate the aggregation behavior of TDP-43
PrLD, TDP-43 PrLD was held constant at 20 lM
and aS concentrations were increased from 1 to
40 lM (0.05, 0.5, 1 or 2 molar equivalents)
(Figure 2(b)). TDP-43 PrLD control aggregated
with lag time of 9.6 h (; Figure 2(b)) while aS did
not show aggregation within the 50-h window (4;
Figure 2(b)). There were small but discernable
decreases in TDP-43 PrLD lag time of
aggregation with the proportional increase in ThT
fluorescence intensities with increasing aS (d;
Figure 2(b)). This effect was most prominent with
the 40 lM aS incubation, which led to no

detectable lag time in TDP-43 PrLD (d; Figure 2
(b)).
In order to monitor the effect of sub-stochiometric
co-incubations of the two proteins, higher
concentration of aS at 50 lM was incubated in
presence of 5 lM (0.1x molar equivalents) and
2 lM (0.04x molar equivalents) TDP-43 PrLD. The
reverse incubations with a higher concentration of
TDP-43 PrLD were prohibitively difficult due to the
increased aggregation propensity of the protein
that showed lag time of smaller than three hours
for 50 lM TDP-43 PrLD (data not shown). The
reactions containing co-incubations of 50 lM aS
with sub-stoichiometric TDP-43 PrLD showed
significant decreases in lag time of aS fibrillization
as compared to either aS or TDP-43 PrLD
controls (Figure 3(a)). The co-incubation with 0.1
and 0.04 molar equivalents showed lag times of
10 and 20 h, respectively (Figure 3(a)) suggesting
TDP-43 PrLD promotes significant aggregation of
aS. After 72 h of incubation, reaction samples
were centrifuged at 18,000g for 20 min to
sediment fibrils formed, if any. Both the samples
before centrifugation and supernatant of
centrifuged samples were then subjected to
immunoblot analysis using Syn211 monoclonal aS
antibody (Figure 3(b)). The blot showed the
presence of a band corresponding to >260 kDa
that failed to enter the gel in both co-incubated
samples (T; Figure 3(b)) in addition to monomeric,
dimeric, and trimeric aS present in all the
samples. The corresponding supernatant samples
did not contain this high molecular weight band (S;
Figure 3(b)) confirming that the high molecular
weight species are sedimentable aggregates or
4
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Figure 3. Interaction of monomeric TDP-43 PrLD and aS in 20 mM MES buffer pH 6.0. (a) ThT fluorescence
kinetics of 50 lM aS alone ( ) and in presence of 0.04 ( ) and 0.1 ( ) molar ratio of TDP-43 PrLD to aS, and
respective 0.04 ( ) and 0.1 (N) TDP-43 PrLD controls. (b) Western blot of ThT reactions using aS antibodies. Aliquot
of sample from the reaction at 72 h was subjected to western blot as total sample (T), and supernatant (S) after
centrifuging at 18,000g (c) Representative fluorescence microscopic images of Thioflavin S (ThS) stained aS and
TDP-43 PrLD aggregation reactions at 72 h after centrifuging at 18,000g (Scale bar = 20 lm). (d and e) Relative
quantification of aS and TDP-43 PrLD to the Cytochrome C internal standard in pellet of reactions and control at 72 h
after centrifugation at 18,000g; 0.1x and 0.04x indicates molar ratio of TDP-43 PrLD to aS.

fibrils. To further ascertain the presence of aS fibrils
in
the
co-incubated
samples,
differential
interference contrast (DIC) microscopy analysis of
the fibrils was employed. The pellet obtained from
the samples centrifuged after 72 h was
resuspended in 20 mM MES buffer pH 6.0 and
incubated with 10 lM thioflavin-S (ThS) and
imaged after 10 min. The images revealed the
presence of higher ThS positive fibrils in the
reaction compared to TDP-43 PrLD and aS
controls (Figure 3(c)). Further quantitative analysis
was carried out to quantitatively assess the
proteins present in the fibrils using MALDI-ToF.
Relative quantitation was performed using a
known amount of cytochrome C (1.42 lmol) as an
external standard that was co-analyzed with the
samples in the mass spectrometer (Figure S1).
Analysis of the data obtained revealed that the
relative amounts of aS in the pellet of reactions
containing 0.1 and 0.04 molar equivalents of TDP43 PrLD were higher compared to the individual
protein controls (Figure 3(d)). However, aS
amount in the supernatant of the control reaction
was significantly higher compared to the reactions
(data not shown), indicating proportional increase
in aS fibrillization upon co-incubation with TDP-43
PrLD. Similar relative quantification of TDP-43

PrLD to standard in the pellets of reaction showed
a higher amount of TDP-43 PrLD than the
respective
controls
indicating
enhanced
fibrillization in presence of aS (Figure 3(e)). Since,
both aS and TDP-43 PrLD were co-observed
within the sedimentable pellets of the crossseeding reactions, we performed qualitative and
quantitative analyses to investigate the presence
of hybrid aggregates. For qualitative analysis,
20 lM TDP-43 PrLD was incubated with 2 lM aS
at 37 °C for 20 h and probed using dot blot
analysis using both aS and TDP-43 antibodies.
We reasoned that since aS does not aggregate
within 72 h (Figure 3(a)); especially at low
concentrations, co-incubation with TDP-43 PrLD
will eliminate the possibility of homotypic aS fibrils
in 20 h. Any aS fibrils thus observed will have to
be due to co-aggregation with TDP-43 PrLD. As
expected, the dot blot analysis of the sample
using aS and TDP-43 antibodies showed
presence of both aS and TDP-43 PrLD confirming
that aS co-aggregates with TDP-43 PrLD during
fibrils formation (Figure S2(a)). Then quantitative
analysis of the aggregates was done by
examining the stoichiometric ratios of two proteins
in the pellets of co-incubated sample containing
equimolar (20 lM) aS and TDP-43 PrLD at 37 °C.
5
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The volume of the reaction was kept high (500 lL)
to recover sufficient amount of fibrils. Fibrils were
then isolated by centrifuging the sample after 7.5
h, the time where the co-incubated reaction had
aggregated faster than the individual proteins
(Figure S2(b) inset). Quantitative MALDI-ToF
analysis using cytochrome C as standard revealed
the presence of both proteins in the fibrils at 1:1.2
ratio of aS to TDP-43 PrLD (Figure S2(b)). This
equimolar distribution of the proteins in the
sedimented pellet is unequivocally indicative of the
formation of hybrid aS-TDP-43 fibrils. Taken
together, the data indicate that both aS and TDP43 PrLD monomers interact with one another and
promote fibrillization synergistically.

seeding of aS monomers by aS sonicated fibrils
showed an immediate increase in ThT intensities
as expected for seeding by elongation
mechanism45 (Figure 4(d)). In contrast, the seeding
of TDP-43 PrLD monomers by aS sonicated fibrils
displayed a more sigmoidal response (Figure 4(d))
but with a shorter lag time of ThT fluorescence to
that of the TDP-43 PrLD control. This suggests that
TDP-43 PrLD monomers may undergo conformational alterations before they grow on aS fibrils. Similarly, homotypic seeding of TDP-43 PrLD
monomers by TDP-43 sonicated fibrils showed
immediate and substantial increases in ThT intensities (Figure 4(e)). But in stark contrast, seeding of
aS monomers by TDP-43 PrLD sonicated fibrils
failed to show interactions (Figure 4(e)). The secondary structure of the cross-seeded reactions from
(c-e) was analyzed by FTIR (Figure 4(f)). The crossseeded reaction of TDP-43 PrLD monomers with
aS sonicated fibrils or DOPAL-derived aS oligomers
displayed a b-sheet structure with an absorbance
peak centered at 1615 cm1 (pink and black; Figure 4(f)) as opposed to the monomeric samples that
show predominantly random coil structure at
1643 cm1 or 1650 cm1 (blue and red; Figure 4
(f)). In contrast, seeding of aS monomers with
TDP-43 PrLD fibrils showed a predominant random
coil structure at 1643 cm1 (green; Figure 4(f)) suggesting minimal or no seeding. Finally, morphological features of the seeded aggregates were
investigated by AFM. Sonicated fibrils of aS and
TDP-43 PrLD showed fragmented aggregates as
expected (Figure 4(g) and (i)). TDP-43 PrLD monomers seeded with sonicated aS fibrils after 8 h of
incubation showed smooth fibrils (Figure 4(h)).
However, aS monomers seeded with TDP-43 PrLD
fibrils did not show fibers after 8 h of incubation (Figure 4(j)). These results are in agreement with kinetics data supporting the observation of the difference
in the ability to seed. Together, these data suggest
that while TDP-43 PrLD monomers seem to be
amenable for seeding by different aS species, aS
monomers are selective towards TDP-43 PrLD
monomers and not sonicated fibrils.

aS oligomers and sonicated fibrils seed
fibrillation of TDP-43 PrLD monomers but aS
monomers are innocuous to seeding by TDP43 PrLD sonicated fibrils
Having established that monomers of aS and
TDP-43 PrLD interact and promote each other’s
aggregation, we questioned if their interactions are
restricted to only monomers or whether oligomers
and sonicated fibrils can also cross-seed
respective monomers. To answer these questions,
dihydroxyphenyl acetaldehyde (DOPAL), a
metabolite of dopamine biogenesis, induced
oligomers of aS were used as de facto oligomers
along with sonicated fibrils of both aS and TDP-43
PrLD. Isolation of stable oligomers of TDP-43
PrLD was not successful and hence were
excluded from the investigation. DOPAL-derived
oligomers of aS were generated and isolated by
size exclusion chromatography (see Materials and
Methods). The aS oligomers showed a
monodisperse peak in dynamic light scattering
(DLS) around 10 nm diameter (Figure 4(a)) with a
molecular weight centered at ~48 kDa (~3mer)
observed in immunoblot along with two faint
bands corresponding to ~33 and 64 kDa species
(2 and 4mers, respectively) (inset; Figure 4(a)).
Moreover, circular dichroism (CD) spectra of the
aS oligomers showed random coiled structure with
characteristic minima at 195 nm (Figure 4(b))
while morphologically they are seen as punctate
spheres of ~4–6 nm height by atomic force
microscopy (AFM) (inset; Figure 4(b)). Incubation
of these oligomers at 0.5 and 1 lM concentrations
with 15 lM of monomeric TDP-43 PrLD in 20 mM
MES at pH 6.0 resulted in decrease in lag time of
TDP-43 PrLD aggregation to ~6 h (Figure 4(c)).
Immunoblot analysis of the samples after 12 h
showed the formation of high molecular weight
fibril bands that is absent in the control sample of
TDP-43 PrLD (inset; Figure 4(c)), clearly
indicating that aS oligomers are able to seed TDP43 PrLD monomers. Seeding of 20 lM monomers
of either aS or TDP-43 PrLD with 1, 2 or 4 lM
sonicated fibrils of TDP-43 PrLD or aS,
respectively showed different behavior. Homotypic

aS modulates LLPS of TDP-43 PrLD and RNA
and induces insoluble aggregates
One of the pivotal roles of TDP-43 in
pathophysiology is that under cellular stress
conditions, they are known to coacervate with
RNA and other proteins to undergo LLPS to form
stress granules (SGs) in the cytoplasm.39,46 To
see whether aS is able to modulate LLPS, TDP43 PrLD was labeled with Hilyte-647 and mixed with
unlabeled TDP-43 PrLD at 1% molar ratio (0.2 lM)
to a final total concentration of 20 lM protein. Similarly, aS was labeled with Hilyte-405 and mixed with
unlabeled protein in 1:99 ratio, and this sample was
used at final concentrations of 5 and 1 lM in 20 mM
MES buffer at pH 6.0 at 37 °C. As expected, TDP43 PrLD spontaneously phase separates in pres6

Journal of Molecular Biology 433 (2021) 166953

S. Dhakal, C.E. Wyant, H.E. George, et al.

Figure 4. Cross-seeding of oligomers and sonicated fibrils with monomers. a) DLS analysis of DOPAL-derived aS
oligomers isolated from SEC. (inset) SEC fraction containing the oligomer ‘o’ used in the study; ‘m’ refers to control
monomer. b) CD spectra and AFM height image (inset) of DOPAL-derived aS oligomers used for cross-seeding
reaction (scale bar = 1 lm). Cross-seeding reactions with monomers of 15 lM TDP-43 PrLD alone ( ) or in the
presence of 0.5 lM ( ) or 1 lM ( ) DOPAL-derived aS oligomers in the presence of 10 lM ThT. (inset) immunoblot of
the reaction after 12 h probed with TDP-43 antibody; ‘c’ refers to TDP-43 PrLD monomer control. d) Seeding of 20 lM
aS monomers with 4 lM (), 2 lM ( ), and 1 lM ( ) of aS sonicated fibrils, and 20 lM TDP-43 PrLD monomers
seeded with 4 lM (d), 2 lM ( ), 1 lM ( ) of aS sonicated fibrils. e) Seeding of 20 lM TDP-43 PrLD monomers with
4 lM (), 2 lM ( ), and 1 lM ( ) of TDP-43 PrLD sonicated fibrils and seeding of 20 lM aS monomers with 4 lM (d),
2 lM ( ), 1 lM ( ) of TDP-43 PrLD seed. f) FTIR analysis of cross-seeding reactions from (c-e). TDP-43 PrLD
monomers cross-seeded with 1 lM DOPAL-derived aS oligomers after 12 h of incubation (—); TDP-43 PrLD
monomers seeded with 1 lM aS sonicated fibrils ( ); aS monomers seeded with 1 lM TDP-43 PrLD sonicated fibrils
( ) along with controls such as aS monomers ( ) and TDP-43 PrLD monomers ( ) (g-j) AFM height image of aS
sonicated fibrils (g), aS sonicated fibrils seeded TDP-43 PrLD monomers (h), TDP-43 PrLD sonicated fibrils (i), and
TDP-43 PrLD sonicated fibrils seeded aS monomers (j) (scale bar = 1 lm, inset = 200 nm).

ence of RNA to form liquid droplets (0 h; Figure 5
(a)). The addition of aS led to instant changes in
the morphology of the droplets to become somewhat distorted, non-spherical structures in both stoichiometric incubations (0 h; Figure 5(a)). The same
reactions monitored after 24 h showed the droplets
becoming more distorted and aggregated as
opposed to the control, which continued to have
well-defined phase-separated liquid droplets (24 h;
Figure 5(a)). To investigate whether the droplet
deformity is due to aggregation, the dynamics of liquid droplets were probed by fluorescence recovery
after photobleaching (FRAP) analysis. The control
TDP-43 PrLD – RNA droplets showed significant
FRAP recovery rates both at 0 h and 24 h indicating

that the samples retained significant fluid characteristics (Figure 5(b) and (c)). However, the FRAP
recovery rates of aS co-incubated TDP-43 PrLD
droplets reduced significantly at 0 h which remained
constant over the period of 24 h with a more dramatic effect with 5 lM than 1 lM aS (Figure 5(b)
and (c)), which suggest gelation or aggregation
samples. To unambiguously confirm if the attenuation of droplet fluidity is due to aggregation, the
same reactions were monitored by ThT. The data
indicated that the ThT fluorescence did not show
much increase in 24 h for the TDP-43 PrLD–RNA
control reaction (; Figure 5(d)). In contrast, samples co-incubated with aS showed increased ThT
fluorescence suggesting aggregation of TDP-43
7
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Figure 5. Modulation of TDP-43 PrLD LLPS by aS. (a) Timestamped confocal images of the co-incubations of
Hilyte-647 labelled TDP-43 PrLD (20 lM) and RNA (40 lug/mL) in the absence and presence of Hilyte 405 labelled
aS (5 or 1 lM) in 20 mM MES buffer pH 6.0 at 37 °C; Bf represents ‘bright field’.(b) FRAP analysis on the selected
droplets from the reactions before (pre-bleach), during (0 sec), and after photobleaching (45 sec), immediately after
incubation (0 h) and after 24 h. (c) Normalized kinetics of fluorescence recovery data obtained from FRAP intensity;
TDP-43 PrLD and RNA control reaction along with 5 lM and 1 lM aS at 0 h ( ) and after 24 h ( ). The data was fit to a
first order exponential growth equation (solid lines). (d) Corresponding ThT fluorescence kinetics of the reactions;
TDP-43 PrLD and RNA () control reaction along with sub-stoichiometric, 1 lM ( ) or 5 lM ( ) aS incubations.

monomers were co-incubated with 5 lM aS monomers (TDP-43 PrLD: aS = 4:1) under identical conditions. The samples were then diluted five-folds
and incubated with freshly cultured SH-SY5Y cells
for additional 24 h. Appropriate control reactions
corresponding to homotypic proteins were also set
up and incubated under similar conditions. Cell viability of the confluent cells was then determined by
XTT assay (see Materials and Methods).47 The
results indicate that in both stoichiometries, only
the co-incubated samples showed higher toxicity
than the homotypic aggregates (Figure 6). Among
the two, 1:4 reaction of TDP-43 PrLD: aS monomers showed a substantially greater degree of toxicity (~40%) as compared to the 4:1 sample (~28%),
suggesting that the effect of sub-stoichiometric
addition of TDP-43 PrLD enhances aS aggregation
and toxicity. In case of cross-seeding of fibrils to
monomers, aS fibrils seeded TDP-43 PrLD aggregation showed a substantial increase in toxicity

PrLD as observed in other reactions ( and ; Figure 5(d)). Taken together, these data suggest that
aS modulate phase separation of TDP-43 PrLD with
RNA and enhance its aggregation.

Cross-seeded heterotypic fibrils are
more cytotoxic than the homotypic
fibrils of aS or TDP-43 PrLD.
Recently, it was found that TDP-43 enhances the
toxicity of aS in dopaminergic neurons resulting in
neurodegeneration.26 Thus, we wanted to investigate and compare the toxicities of heterotypic fibrils
formed by cross-seeding and the homotypic ones
formed by individual aS or TDP-43 PrLD fibrils in
human neuroblastoma SH-SY5Y cells. In order to
accomplish this, 20 lM aS monomers were coincubated with 5 lM TDP-43 PrLD monomers
(TDP-43 PrLD: aS = 1:4) in quiescent conditions
for 24 h at 37 °C. Similarly, 20 lM TDP-43 PrLD
8
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Figure 6. Cytotoxicity of monomeric aS and TDP-43 PrLD species along with homotypic and heterotypic fibrillar
species of aS and TDP-43 in SH-SY5Y cells by XTT assay. ‘m’, ‘o’ and ‘f’ in the superscript represents monomer,
oligomer, and sonicated fibril respectively. All the data were obtained in triplicates, * represents p < 0.1 and
**represents p < 0.01 based on one-way ANOVA analysis.

(~41%) compared to the aS fibril seeds or TDP-43
PrLD monomers (<20%) (Figure 6). TDP-43 PrLD
fibril seeded aS aggregation did not show an
increase in toxicity compared to the controls. These
results correlate with the kinetics and morphology of
the seeding reaction in which only aS fibrils seeded
TDP-43 PrLD aggregation showed aggregation
(Figure 4). Similarly, the addition of aS monomers
to the liquid droplets of TDP-43 PrLD and RNA that
promoted insoluble fibrils also showed an increase
in toxicity (~30%) as compared to TDP-43 PrLDRNA control (<20%). In contrast to these results,
only aS oligomer (DOPAL-induced) seeded TDP43 PrLD fibrils did not show a statistically significant
increase in toxicity (Figure 6). One of the main reasons for this result is due to the fact that aS oligomer
is DOPAL-induced and not a bonafide aggregation
pathway intermediate; clearly, DOPAL-induced aS
oligomers showed maximum toxicity (~57%; Figure 6). Therefore, it is possible that fibrils of TDP43 PrLD seeded by these oligomers do not display
any higher degree of toxicity. Together, these data
suggest that the synergistic interactions between
TDP-43 PrLD and aS lead to the formation of hybrid
fibrils which are more toxic than those of their individual proteins.

on mass spectrometric analysis of post-mortem
brain samples, enhanced levels TDP-43 Cterminal truncation fragment of 266–414 (corresponds to TDP-43 PrLD) was observed in ALS
and AD patients.38 Second, TDP-43 CTFs are primarily involved in the formation of cytoplasmic inclusions generated upon aberrant proteolytic cleavage
of the full-length TDP-43 under pathological conditions in which PrLD plays a major role.33,42,52 Third,
CTFs ranging between 35 and 18 kDa are also produced by alternative splicing of TDP-43 mRNA and
are linked to pathology.51,53 Fourth, the PrLD of
TDP-43 is known to play a major role in SG formation, aggregation as well as protein–protein interactions.54–56 Lastly, almost all pathogenic mutations
lie within PrLD42,57 implying its significance in
pathophysiology.
The results presented here demonstrate
synergistic interactions between TDP-43 PrLD and
aS, which in part, recapitulate the pathobiological
observations. Rapid aggregation of the two protein
monomers upon co-incubation (Figure 1(g)), and
the concomitant increases in aS or TDP-43 PrLD
aggregation rates (Figure 2) suggest a synergistic
aggregation possibly during nucleation. In
addition, seeding of TDP-43 PrLD by both
oligomers and sonicated fibrils of aS also shows
cross-interaction between the two proteins. These
results collectively suggest a possible heteronucleation mechanism predominating at the initial
stages of aggregation and elongation mechanism
at the later stages. The results also bring out
mechanistic differences in their interactions; the
data indicate that the three key aS species such
as monomers, oligomers and sonicated fibrils are
indiscriminate in interacting with and getting
modulated by TDP-43 PrLD monomers (Figure 7).
However, only monomeric TDP-43 PrLD, and not

Discussion
The work reported here is focused on the effects
of TDP-43 PrLD on aS and vice versa. We chose to
focus on PrLD instead of the full-length TDP-43 for
a variety of reasons; First, the post-mortem ALS
and FTD brain tissues show an abundance of
TDP-43CTFs ranging between 35 and 18 kDa (35,
25, 20, and 18 kDa),48–51 all of which constitute
PrLD (17 kDa) a major part. In a more recent study
9
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Figure 7. Schematic diagram summarizing the collective results from this work. The square parenthesis indicates
theoretical transient oligomers and not used in this study. ‘*’ DOPAL-derived de facto intermediate oligomers but
shown along the aggregation pathway for simplicity.

the sonicated fibrils, seem to preferentially interact
with aS monomers and aggregates (Figure 7).
From these results, one may conjecture that early
stages of TDP-43 proteinopathies may be
susceptible to modulation by the presence of aS
aggregates in the form of Lewy bodies.
Furthermore, the interaction of TDP-43 PrLD and
aS monomers seem to be cooperative with both
assisting one another in promoting high molecular
weight aggregates expeditiously. We also deduce
that co-incubation of monomers is likely to form
aS-TDP-43 PrLD hybrid aggregates based on
both qualitative and quantitative evidence
(Figure
S2(a)
and
(b));
a)
synergistic
augmentation in the rate of aggregation of both
proteins, and b) the observed molar equivalents of
both proteins within the sediments fibrils.
However, the data also show that aS monomer,
oligomer and fibrils are equally capable of
interacting with TDP-43 PrLD monomers
(Figure 7) and hence, the possibility of
mechanisms
such
as
nucleation-assisted
aggregation and protofibril elongations are likely
between the two proteins as mentioned earlier.
But one also cannot discount other possible

mechanisms such as heterologous secondary
nucleation, fibril fragmentations and epitaxial
growth, which remain to be investigated. Another
interesting observation is that the effect of TDP-43
PrLD on aS is far more pronounced than vice
versa. This is partly due to aS being relatively
slow to aggregate as compared to TDP-43 PrLD;
for example, the lag times for aS and TDP-PrLD
(20 lM) aggregation at 37 °C and in identical
quiescent buffer conditions are >7 days and 8 h,
respectively (data not shown). Therefore,
augmentation of aS aggregation by TDP-43 PrLD
is readily comprehensible as the lag time of
aggregation is reduced to 20 h from weeks
(Figure 3(a)). On the other hand, the effect of aS
on TDP43 PrLD is discernable but subtle (Figure 2
(b)). This is especially true with DOPAL-derived
aS aggregates which augment TDP-43 PrLD
aggregation significantly (Figure 4(c)). Previous
studies have shown that the interaction of
dopamine with aS results in the formation of
structurally distinct oligomers.58,59 In particular,
small angle X-ray scattering of aS trimers formed
in the presence of dopamine has revealed wormlike shape due to laterally associated monomers
10
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without end-to-end arrangement.60 Such trimers
are different from those formed in the absence of
dopamine exhibiting spherical, chain like or ring like
annular structure. Along similar lines, we anticipate
that DOPAL-derived aS oligomers will be different
both structurally and functionally mainly based on
the fact that DOPAL forms covalent, Schiff’s base
adduct with aS. aS sonicated fibrils seeding of
TDP-43 PrLD monomers show a cooperative
mechanism with a delay in elongation, which could
indicate conformational reorganization of TDP-43
monomers induced by aS sonicated fibrils. On the
other hand, TDP-43 PrLD sonicated fibrils failed to
interact with aS monomers suggesting possible
incompatibility of TDP-43 PrLD sonicated fibrils
structure to seed. Clues about the structural basis
of interactions come from the NMR data, which
shows that the TDP-43 PrLD seem to preferentially
interact with aS on the N-terminal and C-terminal
ends of the protein (1–60 and 100–140, respectively) based on the large chemical shift changes
observed, while augmenting aggregation via the
amyloidogenic core NAC region (61–95) (Figure 1
(c)). This is readily comprehensible given that the
N- and C-terminal ends of aS are hydrophilic and
acidic, they could interact electrostatically with
highly positively charged TDP-43 PrLD bringing
the amyloidogenic NAC region of aS in close proximity to augment aggregation. Unfortunately, similar
structural information on TDP-43 PrLD was undecipherable due to rapid aggregation of TDP-43 PrLD
and consequent dilution of chemical shifts. Collectively, these data bring forth the synergistic yet
selective interactions between broad categories of
aS and TDP-43 PrLD species. Yet another significant aspect that highlights the interaction between
the two proteins is the ability of aS to modulate
LLPS of TDP-43 PrLD and RNA and promote insoluble aggregates. Since these droplets are the main
constituents of cytoplasmic SGs, these results
demonstrate crucial yet hitherto unseen interactions
that may hold significance in neurodegenerative
diseases with co-morbidities. Perhaps the most significant of all is the observation that only the hybrid
aggregates show far greater cellular toxicity as
opposed to the individual aggregates, which suggests that co-morbidities in these pathologies are
better defined by the cross-talk between TDP-43
and aS.
It is well-known that aggregates of aS and TDP43
individually
are
observed
in
many
neurodegenerative pathologies including AD, PD,
Huntington’s disease, FTD, etc.11,61–63 The term
‘synucleinopathies’ has come to define some of
the pathologies in which aS aggregates play a causative or a propagative role(s). In the last decade,
aggregates of TDP-43 have also been increasingly
observed in as many pathologies in which aS
aggregates have been observed15 invoking a compelling argument to categorize some of these maladies as TDP-43 proteinopathies. However, more

interesting is the significant overlap between
pathologies in which both aggregates of TDP-43
and aS aggregates are observed. Indeed, many
reports have indicated the colocalization of TDP43 and aS aggregates27,64 implicating potential
interactions between the two proteins to play a role
in these pathologies. The data presented here
unequivocally demonstrate the interactions
between these two proteins which may underlie
the clinical and pathological observations, and open
doors to deeper investigations in establishing mechanistic links to co-morbidities in neurodegenerative
diseases.

Methods
Expression and purification of recombinant
proteins
Expression and purification of both unlabeled and
N labeled recombinant TDP-43 PrLD was
performed as described previously.40 TDP-43 PrLD
fusion construct (Addgene plasmid #98669) with
hexahistidine tag followed by tobacco etch virus
(TEV) cleavage site at N-terminus was transformed
in BL21 StarTM (DE3) cells, protein expression was
induced using 0.5 mM IPTG (Life Technologies)
and purified by Ni-NTA affinity chromatography.
Briefly, cells were resuspended in lysis buffer
(20 mM Tris, 500 mM NaCl, 5 mM imidazole, pH
8.0) and 0.5 mM PMSF was added. Cells were
lysed using sonication (Misonix XL-2000) and centrifuged at 20,000g for one hour to remove any cellular debris. Supernatant was incubated with NiNTA beads for two hours at 4 °C prior to purification
and loaded into the column. Impurities were
removed by increasing the imidazole concentration
in buffer (20 mM Tris pH 8.0, 500 mM NaCl and 6 M
urea), 15 mM and 30 mM. Finally, protein was
eluted using elution buffer containing 150 mM imidazole followed by buffer exchanged with storage
buffer containing 20 mM Tris pH 8.0, 500 mM NaCl,
2 M urea and stored at 80 °C. Concentrated aliquots of protein in storage buffer at 80 °C was
thawed on ice and desalted in 20 mM MES buffer
pH 6.0 using Zeba Desalting Spin Columns
(Thermo) and immediately used for the
experiments.
Both unlabeled and 15N labeled recombinant fulllength aS was expressed and purified in RosettaTM 2
(DE3) pLysS (EMD MilliporeÒ) cells using
IMPACTTM system protocol (New England
BiolabsÒ) as described before,65 with few modifications. Briefly, aS detached from chitin beads using
dithiothreitol (DTT) was eluted in elution buffer
(20 mM Tris, 100 mM NaCl, 1 mM EDTA at pH
8.0). The eluted fraction was filtered using 30 kDa
centrifugal filter units (Thermo) at 7000g for 20
min. The flow-through was dialyzed against 4L of
nanopure water in a 10 kDa dialysis bag to remove
DTT and concentrated using a vacufuge. Concentrated aS was directly subjected to reverse phase
15
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HPLC purification by the gradient elution of water
and acetonitrile (ACN) each containing 0.1% TFA.
HPLC fractions containing pure protein were lyophilized and stored at 80 °C. Lyophilized samples
were resuspended in 20 mM MES pH 6.0 and subjected to size exclusion chromatography (SEC) to
remove any preformed aggregates and thus
obtained pure monomeric protein was used as such
for studies. Due to better yields, another aS construct containing N-terminus 6-histidine tag and a
thrombin cleavage site was also used occasionally
in this study. The protein was expressed in BL21
(DE3) cells, purified using Ni-NTA affinity chromatography and concentrated using 10 kDa centrifugal filter unit. Concentrated protein was further
subjected to SEC and the fractions corresponding
to the monomeric protein were used in the experiments. Unused monomer fractions were stored at
4 °C and were used within a week from purification.
We confirmed that aS purified using both constructs
have similar biophysical characteristics and aggregation kinetics.

SDS-PAGE and immnoblotting
Aliquots of the reactions were subjected to SDSPAGE and immunoblotting using a monoclonal
anti-aS antibody, clone Syn211 (Millipore Sigma).
Aliquots of the samples were separately mixed in
the 4x Laemmli sample buffer and loaded onto
SDS-PAGE Biorad Mini-PROTEANÒ 4–20%
precast gel. Gels were then transferred on to a
0.45
lM
Amersham
Protran
Premium
nitrocellulose membrane (GE Life Sciences) and
the blot was boiled in 1X PBS for one minute. For
dot blot analysis, pellet obtained from aS and
TDP-43 co-incubation reaction was treated with
formic acid, resuspended in 20 mM MES buffer
pH 6.0 and was directly spotted in the
nitrocellulose membrane. Blot was then incubated
overnight in the blocking buffer (5% non-fat milk,
0.1% TweenÒ-20 in 1X PBS), followed by primary
antibodies against aS or TDP-43 PrLD and
horseradish peroxidase-conjugated anti-mouse/
anti-rabbit secondary antibodies. Finally, images
were obtained by treating with ECL reagent using
GelDoc molecular imager (Bio-Rad).

Preparation of aS oligomers, aS fibrils and
TDP-43 PrLD fibrils

MALDI-ToF mass spectrometry

aS oligomers and fibrils were generated similar to
previous protocols.66,67 Briefly, aS oligomers have
been generated by incubating 50 lM aS monomer
with 20-fold molar excess of 3,4-Dihydroxyphenyla
cetaldehyde (DOPAL) at 600 rpm at 37 °C for 24
h. Oligomers of aS were isolated using superdex200 size exclusion chromatography (SEC) column
in 10 mM Tris pH 8.0. Fibrils of aS were prepared
by incubating 5 mg of monomeric protein in presence of 150 mM NaCl at 600 rpm at 37 °C for 7 days.
Similarly, TDP-43 PrLD fibrils were generated by
incubating 50 lM monomeric TDP-43 in quiescent
condition at 37 °C for 7 days. Both fibrils were isolated by centrifuging at 20,000g for 20 min and
stored at 80 °C until use.

Quantification of aS and TDP-43 PrLD fibrils was
performed on a Bruker Datonics Microflex LT/SH
MALDI-ToF system. Aliquots of samples from
aggregation reactions after 48 h were centrifuged
at 18,000g for 20 min. The supernatant was
discarded and the pellet was washed and
resuspended in an equal volume of 20 mM MES
buffer pH 6.0. Resuspended pellets were then
mixed with an equal volume of formic acid to
disaggregate the fibrils. The samples were then
mixed with Cytochrome C external standard at
1.42 lM final concentration in 1:1 sinnapinic acid
matrix and loaded on to an MSP 96 BC MALDI
plate (Bruker Datonics). The instrument was
calibrated using Bruker Protein Calibration
Standard I (Bruker Datonics) and spectra were
collected by adjusting the laser intensity at 70%.

Thioflavin-T (ThT) fluorescence

Circular dichroism

Aggregation kinetics were monitored using
BioTek Synergy H1 microplate reader. Samples
containing 10 lM ThT were excited at 452 nm and
emission was monitored at 485 nm at 37 °C. The
data points were plotted as ThT fluorescence
versus time and fitted with following Boltzmann
sigmoidal function using Origin 8.5.

Circular dichroism (CD) spectra of 4.25 lM
DOPAL-derived aS oligomers in 10 lM Tris buffer
pH 8.0 was measured in far UV region (190 to
260 nm) in Jasco J-815 spectrophotometer (Jasco
MD) as previously.68

y ¼ A2 þ

Fourier transform infrared (FTIR) spectroscopy
Lyophilized sample of monomeric aS and TDP-43
PrLD along with aggregates from cross-seeding
reaction were dissolved in D2O and subjected to
Cary 630 FTIR spectrometer. A total of 1024
scans were collected from 1800 cm-1 to 1400 cm-1
at a resolution of 4 cm-1. Spectra were blank
subtracted with D2O, normalized and plotted in
OriginLab 8.0 program.

ðA1  A2 Þ
1 þ e ðx x 0 Þ=dx

In this equation, y corresponds to ThT
fluorescence intensity, x is time and xo is the time
to reach half-maximal ThT fluorescence and A1
and A2 are constants. The lag time of aggregation
was calculated as xo  2dx for each fitted curve.
12
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University of Alabama, Birmingham as described
previously.70,71 Briefly, SOFAST HMQC was collected as it allows reduction of the recycle delays
to 100 ms while maintaining high sensitivity, and
decreasing the overall acquisition time.69 The protein concentrations were kept at 10 lM for both proteins with 1:1 molar equivalents of unlabeled
proteins added for interaction studies. The spectra
were then collected with 2048 data points in F2
(1H) with 128 scans coadded for each of the 160
F1 (15N) increments. A 1J(NH) of 90 Hz was used
with a 100 ms relaxation delay. The delay interval
from F1 to F2 was set at 0.32 ms. The raw HMQC
spectra were processed using Bruker TopSpin 3.5
analysis software with standard methods with
phase corrections in both dimensions. Crosspeaks of both aS and TDP-43 PrLD were identified
as in previous studies.47,55,72

Dynamic light scattering (DLS)
DLS was carried out in a Zetasizer Nano S
instrument (Malvern, Inc.) by averaging 3 runs
each of 10 s with a pre-equilibration time of 30 s.
Sample volume was kept at 70 lL in a 1 cm
cuvette pathlength. Finally, diameter was
determined using volume (%) function and plotted
in origin 8.0.
Fluorescence microscopy
Fluorescence microscopic images of the reaction
with labeled proteins were obtained using Leica
SP8 confocal microscope at 40x magnification in a
clear glass bottom 96 well black plates (P96-1.5HN, Cellvis Inc.). Briefly, protein labeling was
carried out by incubating three molar excess of
fluorescent dyes, Hilyte 405 or Hilyte 647
(AnaSpec Inc) with the proteins for 12 h at 4 °C.
Excess dye was removed using PD SpinTrapTM G25 (Cytiva Life sciences) columns and the labeled
and unlabeled protein samples were mixed in 1:99
ratio and used for the experiments. We do not
expect the Hilyte dyes to have any discernable
effects on our observations as they are
comparable to routinely used xanthane dyes.
Moreover, to minimize their effects if any, we used
only 1% of total protein with labeled ones in our
assays. For thioflavin-S (ThS) staining, aliquots of
samples from the reactions were centrifuged at
18,000g for 20 min, and pellets were resuspended
in 20 mM MES buffer pH 6.0. ThS was added at a
final concentration of 10 lM and incubated for 10
min prior to imaging.

Atomic force microscopy
AFM images were obtained following a previously
published method.73 Briefly, mica was cleaved
using tape then attached to a magnet. The mica
was then treated with 150 lL of 3aminopropyltriethoxysilane
(APTES)
solution
(500 lL of 3-aminopropyltriethoxysilane in 50 mL
of 1 mM acetic acid) for 30 min. The APTES solution
was then decanted off and the mica substrate was
rinsed three times with nanopure H2O, dried with
N2, and stored for an hour. The 1–4 lM reaction
samples were diluted to 100-folds and a volume of
150 lL of the sample solution was deposited onto
the mica surface and were allowed to absorb for
30 min. The sample solution was then decanted
from the mica surface and washed with 150 mL of
nanopure H2O three times, dried with N2, and stored
in a desiccator until imaging. AFM analysis was performed using a Dimension Icon atomic force microscope (Bruker) in PeakForce Tapping mode. AFM
scanning was performed using NanoScope
8.15r3sr5 software and the images were analyzed
in NanoScope Analysis 1.50 software. Imaging
was performed using a sharp silicon nitride cantilever (SNL-C, nominal tip radius of 2 nm; nominal
resonance frequency of 56 kHz; nominal spring
constant of 0.24 N/m) and a standard probe holder
under ambient conditions with 512  512 data point
resolution. Multiple areas of the mica surface were
analyzed, height and phase images were obtained
simultaneously, and representative images are
reported.

Fluorescence recovery after photobleaching
(FRAP)
Hilyte 647 labeled TDP-43 PrLD and RNA
reaction with or without Hilyte 405 labeled aS was
monitored using FRAP. The samples were
photobleached using 100% laser intensity for 10
seconds with 141 iterations and recovery was
monitored for 45 seconds. The FRAP kinetic data
was plotted as normalized fluorescence with
reference to TDP-43 PrLD and RNA control and
was fit using Boltzmann function on Origin 8.5.
NMR spectroscopy
The NMR experiments were carried out using 15N
labeled aS and TDP-43 PrLD in 20 mM MES, pH
6.0 with 10% D2O after incubation with and
without unlabeled TDP-43 PrLD and aS proteins.
For these experiments, N-terminus histidine-tag
was removed from TDP-43 PrLD using TEV
protease.55 SOFAST heteronuclear multiple quantum coherence (HMQC)69 spectra were obtained
on the samples at 10 and 37 °C. The data were
acquired on a Bruker Advance- III-HD 850 MHz
NMR spectrometer equipped with a Bruker TCI
cryoprobe at the high-field NMR facility of the

Cell viability XTT assay
Cell viability was measured using 2,3-bis(2-meth
oxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbo
nyl]- 2H– tetrazolium hydroxide (XTT) assay kit
(Biotium) following the previously established
protocol with few modifications.74 Briefly, human
neuroblastoma SH-SY5Y cells (ATCC, Manassas,
VA) were maintained in a humidified incubator at
13
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37 °C with 5.5% CO2 in 1:1 mixture of DMEM and
Ham’s F12K medium with 10% FBS and 1% penicillin/streptomycin. Approximately, 15,000 cells
were plated in a clear bottom 96 well black plates
(Thermo Scientific) 24 h prior to sample treatment.
All the reaction samples were prepared and purified
using autoclaved water and buffer to avoid bacterial
contamination. Cell medium from wells was
replaced with the reaction samples resuspended
in complete growth medium and incubated for 24
h prior to XTT assay.

Keywords:
a-synuclein;
TDP-43;
fibrillization;
amyloid;
liquid–liquid phase separation
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Höftberger, R., et al., (2017). Tau pathology in CreutzfeldtJakob disease revisited. Brain pathol., 27, 332–344.
11. Hamilton, R.L., (2000). Lewy bodies in Alzheimer’s
disease: a neuropathological review of 145 cases using
a-synuclein Immunohistochemistry. Brain Pathol., 10, 378–
384.
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